trending Market Intelligence /marketintelligence/en/news-insights/trending/fbbfj7u4i8hvl_sb0o95pg2 content esgSubNav
In This List

Vericel plans common stock offering

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Vericel plans common stock offering

Vericel Corp. is planning a public offering of 3,750,000 common shares to raise funds for general corporate purposes.

Leerink Partners is acting as the lead book runner while BTIG LLC is acting as a book runner for the offering.

The Cambridge, Mass.-based biopharmaceutical company intends to grant the underwriters a 30-day option to buy up to an additional 562,500 common shares.